Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso
Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso
Not yet recruiting · NCT07730177 · Registry updated 2026-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 1 | 2026-07-31 | NCT07730177 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Groupe de Recherche Action en Sante | 1 |
| Sanaria Inc. | 6 |
| Seattle Children's Hospital | 97 |
| University of California, Los Angeles | 355 |
| University of Maryland, Baltimore | 198 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Groupe de Recherche Action en Santé (GRAS)/Unité de Recherche Clinique de Sabou | Ouagadougou | Burkina Faso | 1 |